These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38423892)

  • 1. Racial disparities in rates of invasiveness of resected intraductal papillary mucinous neoplasms in the United States.
    Allen WE; Greendyk JD; Alexander HR; Beninato T; Eskander MF; Grandhi MS; In H; Kennedy TJ; Langan RC; Maggi JC; Moore DF; Pitt HA; De S; Haider SF; Ecker BL
    Surgery; 2024 May; 175(5):1402-1407. PubMed ID: 38423892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical indication for intraductal papillary mucinous neoplasm without mural nodule ≥5 mm.
    Tsumura A; Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Hayami S; Ueno M; Yanagisawa A; Yamaue H
    Surgery; 2021 Feb; 169(2):388-395. PubMed ID: 32859391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.
    Chari ST; Yadav D; Smyrk TC; DiMagno EP; Miller LJ; Raimondo M; Clain JE; Norton IA; Pearson RK; Petersen BT; Wiersema MJ; Farnell MB; Sarr MG
    Gastroenterology; 2002 Nov; 123(5):1500-7. PubMed ID: 12404225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special reference to the incidence of concomitant pancreatic ductal adenocarcinoma.
    Date K; Ohtsuka T; Nakamura S; Mochidome N; Mori Y; Miyasaka Y; Oda Y; Nakamura M
    Surgery; 2018 Feb; 163(2):291-299. PubMed ID: 29221879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
    Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enucleation: A treatment alternative for branch duct intraductal papillary mucinous neoplasms.
    Kaiser J; Fritz S; Klauss M; Bergmann F; Hinz U; Strobel O; Schneider L; Büchler MW; Hackert T
    Surgery; 2017 Mar; 161(3):602-610. PubMed ID: 27884612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas.
    Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
    JAMA Surg; 2017 Mar; 152(3):e165054. PubMed ID: 28122068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival comparison of invasive intraductal papillary mucinous neoplasm versus pancreatic ductal adenocarcinoma.
    Takeda Y; Imamura H; Yoshimoto J; Fukumura Y; Yoshioka R; Mise Y; Kawasaki S; Saiura A
    Surgery; 2022 Jul; 172(1):336-342. PubMed ID: 35197219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with a resected pancreatic mucinous cystic neoplasm have a better prognosis than patients with an intraductal papillary mucinous neoplasm: A large single institution series.
    Griffin JF; Page AJ; Samaha GJ; Christopher A; Bhaijee F; Pezhouh MK; Peters NA; Hruban RH; He J; Makary MA; Lennon AM; Cameron JL; Wolfgang CL; Weiss MJ
    Pancreatology; 2017; 17(3):490-496. PubMed ID: 28416122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal papillary mucinous neoplasm.
    Shi C; Hruban RH
    Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term (10-year) outcomes and prognostic factors in resected intraductal papillary mucinous neoplasm tumors in Finland: A nationwide retrospective study.
    Vaalavuo Y; Vornanen M; Ahola R; Antila A; Rinta-Kiikka I; Sand J; Laukkarinen J
    Surgery; 2023 Jul; 174(1):75-82. PubMed ID: 37062604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological evaluation of resected intraductal papillary mucinous neoplasms reveals distinct patterns of invasion in associated carcinomas.
    Rift CV; Lund EL; Scheie D; Hansen CP; Hasselby JP
    Hum Pathol; 2021 Jul; 113():47-58. PubMed ID: 33915115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term surveillance is necessary after operative resection for intraductal papillary mucinous neoplasm of the pancreas.
    Hirono S; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
    Surgery; 2016 Aug; 160(2):306-17. PubMed ID: 27236360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic Resection for Side-Branch Intraductal Papillary Mucinous Neoplasm (SB-IPMN): a Contemporary Single-Institution Experience.
    Dortch JD; Stauffer JA; Asbun HJ
    J Gastrointest Surg; 2015 Sep; 19(9):1603-9. PubMed ID: 26055134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus in intraductal papillary mucinous neoplasms: A systematic review and meta-analysis.
    Pergolini I; Schorn S; Jäger C; Göß R; Novotny A; Friess H; Ceyhan GO; Demir IE
    Surgery; 2021 Feb; 169(2):411-418. PubMed ID: 32838986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire.
    Aleotti F; Crippa S; Belfiori G; Tamburrino D; Partelli S; Longo E; Palumbo D; Pecorelli N; Lena MS; Capurso G; Arcidiacono PG; Falconi M
    Surgery; 2022 Oct; 172(4):1202-1209. PubMed ID: 35667898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
    Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
    Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
    McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
    Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.